Comparative evaluation of doxofylline and theophylline in patients of mild bronchial asthma

Md Faiz Akram, Mohammad Nasiruddin, Zuber Ahmad, Rahat Ali Khan

Abstract


Background: Asthma is common chronic disease worldwide. Methylxanthines has been used in the treatment of asthma. The study was undertaken to compare two Methylxanthines theophylline and doxofylline at doses recommended and commonly used in clinical practice in Mild Bronchial Asthma Patients.

Methods: Study was conducted in patients of Mild Bronchial Asthma in TB and chest disease department of a medical college hospital. It was randomized, prospective and open label. A total of 107 patients were divided in two group .Group I was administered 400 mg theophylline SR once daily and group II was administered doxofylline 400 mg twice a day orally. Spirometric variables symptom score, and adverse effects were recorded on day 0, 7 and 21 of therapy. Data were compared and analysed using SPSS version 16.

Results: Results of the study showed that there was significant improvement in spirometric variables and clinical symptom score compared to pretreatment values after medication in both groups on 7th and 21st days of treatment. But there was no statistically significant difference between improvement in theophylline and doxofylline groups with respect to spirometric variables and symptom score. There was no significant difference in two groups with respect to side effects (p>0.05).

Conclusions: It is concluded in Patients of mild Bronchial Asthma Theophylline and doxofylline improve the spirometric and clinical symptoms and doxofylline has no advantage over theophylline in terms of either efficacy or safety on the doses commonly used in current clinical practice.


Keywords


Methylxanthines, Theophylline, Doxofylline, Mild Asthma, Bronchodilators, Histone Deacetylation

Full Text:

PDF

References


Global Initiative for Asthma - Global strategy for Asthma Management and Prevention. Revised 2012 Page 16. www.ginasthma.org.

Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469-78.

A.N. Aggarwal, K. Chaudhry, S.K. Chhabra et al. Prevalence and Risk Factors for Bronchial Asthma in Indian Adults: A Multicentre Study. Indian J Chest Dis Allied Sci 2006;48:13-22.

McFadden ER. Methylxanthines in the treatment of asthma: the rise, the fall, and the possible rise again. Ann Intern Med 1991;115:323-4.

Global Initiative for Asthma - Global strategy for Asthma Management and Prevention. Revised 2012 Page 30 www.ginasthma.org.

Barnes PJ, Pauwels RA. Theophylline in asthma: time for reappraisal? Eur Respir J 1994;7:579-91.

Ito K, Lim S, Chung KF, Barnes PJ, Adcock IM. Theophylline enhances histone deacetylase activity and restores glucocorticoid function during oxidative stress [abstract]. Am J Respir Crit Care Med 2002;165:A625.

Dini FL, Cogo R. Doxofylline: A New Generation Xanthine Bronchodilator Devoid of Major Cardiovascular Adverse Effects. Current Medical Research and Opinion 2001; 16:258-68.

Goldstein MF, Chervinsky P. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma. Med Sci Monit 2002;8:297-304.

Melillo G, Balzano G, Jodice F, De Felice A, Campisi V, Capone M, et al. Treatment Of Reversible Chronic Airways Obstruction With Doxofylline Compared With Slow Released Theophylline: A Double Blind Randomised Multicentre Trial. Int J Clin Pharm Res 1989;IX(6):397-405.

Marc F Goldstein, Paul Chervinsky. Efficacy and safety of Doxofylline compared to Theophylline in chronic reversible asthma a double blind randomized placebo controlled multicentric trial. Med Sci Monit 2002;8(4):CR297-304.

Global Initiative for Asthma - Global strategy for Asthma Management and Prevention. Revised 2012 Page 34 www.ginasthma.org.

Dahl R, Larsen BB, Venge P. Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. Respir Med 2002;96:432-8.

Barnes PJ, Pauwels RA. Theophylline in asthma: time for reappraisal? Eur Respir J 1994;7:579-91.

Global Initiative for Asthma - Global strategy for Asthma Management and Prevention. Revised 2012 Page 34 www.ginasthma.org.

Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-8.